Key Financial Figures - Standalone (Rs. in Lakhs)
Quarterly Performance (Q4 FY26 vs Q4 FY25):
- Revenue from operations: ₹84,553 (Q4 FY26) vs ₹81,367 (Q4 FY25)
- Total income: ₹101,729 (Q4 FY26) vs ₹95,026 (Q4 FY25)
- Loss before tax: ₹(29,932) (Q4 FY26) vs ₹(18,973) (Q4 FY25)
- Loss after tax: ₹(34,039) (Q4 FY26) vs ₹(23,170) (Q4 FY25)
- Basic EPS: ₹(19.14) (Q4 FY26) vs ₹(13.05) (Q4 FY25)
Annual Performance (FY26 vs FY25):
- Revenue from operations: ₹312,026 (FY26) vs ₹316,812 (FY25)
- Total income: ₹356,847 (FY26) vs ₹345,700 (FY25)
- Loss before tax: ₹(68,571) (FY26) vs ₹(41,959) (FY25)
- Loss after tax: ₹(70,828) (FY26) vs ₹(42,830) (FY25)
- Basic EPS: ₹(39.83) (FY26) vs ₹(24.12) (FY25)
- Net worth: ₹187,284 (FY26) vs ₹253,976 (FY25)
Exceptional Items - Standalone (Rs. in Lakhs)
The company recognized exceptional items totaling ₹(829.76) crore for FY26, comprising:
- Impairment of investment in subsidiary: ₹(40,060) lakhs
- Remeasurement of financial guarantee and loan commitment: ₹(59,132) lakhs
- Reversal of impairment of investment in subsidiary and joint venture: ₹221 lakhs
- Profit on sale of investment in Coromandel International Limited: ₹29,764 lakhs
- Impairment of property, plant and equipment: ₹(13,769) lakhs
Subsidiary Closure Details
The Board of Directors of the Company and its wholly owned subsidiary Parry Sugars Refinery India Private Limited (PSRIPL) approved closure of operations of PSRIPL's sugar refinery unit effective close of working hours on March 31, 2026. The closure decision was due to adverse global market conditions, higher operating costs, operational disruptions, and sustained losses making the business unviable.
Financial Support to PSRIPL
Subsequent to year end, the Company infused equity of ₹61,000 lakhs (610,000,000 equity shares of ₹10 each) into PSRIPL and committed to provide additional financial support in the form of loan up to ₹13,000 lakhs to meet obligations arising from closure.
Capital Structure Impact
- Paid-up equity share capital: ₹1,779 lakhs (FY26) vs ₹1,778 lakhs (FY25)
- Pursuant to exercise of stock options, the Company allotted 94,423 equity shares during FY26 (FY25: 260,703 shares)
- During the year, the Company made further investment of ₹35,000 lakhs in its wholly owned subsidiary PSRIPL
Segment Performance - Standalone (Rs. in Lakhs)
Revenue by Segment (FY26):
- Sugar: ₹156,950
- Co-generation: ₹12,168
- Distillery: ₹115,137
- Nutraceuticals: ₹3,259
- Consumer Products: ₹60,715
Segment Results (Profit/Loss before tax) (FY26):
- Sugar: ₹(1,120)
- Co-generation: ₹(4,677)
- Distillery: ₹(1,379)
- Nutraceuticals: ₹26
- Consumer Products: ₹(10,852)
Consolidated Financial Performance (Rs. in Lakhs)
Quarterly Performance (Q4 FY26):
- Revenue from operations: ₹788,233
- Profit before tax: ₹(16,234)
- Loss after tax: ₹(28,717)
Annual Performance (FY26):
- Revenue from operations: ₹3,853,408
- Profit before tax: ₹210,333
- Profit after tax: ₹138,045
- Basic EPS: ₹32.03
Corporate Calendar
- 51st Annual General Meeting scheduled for Wednesday, August 12, 2026, through Video Conferencing/Other Audio-Visual Means
Management Commentary
Mr. Muthiah Murugappan, Whole-time Director and CEO, stated that FY2025-26 was challenging and emphasized disciplined execution, operational efficiency, and portfolio reshaping. The company focused on working capital management, cost improvement, and building a resilient operating model across business verticals.
Additional Information
- Due to seasonal nature of business, figures for current and previous quarters are not comparable
- The figures for current quarter are balancing figures between audited full year and published year-to-date figures up to third quarter
- Subsequent to balance sheet date, Coromandel International Limited approved final dividend of ₹2 per share (estimated dividend inflow for Company: ₹3,279 lakhs)